Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Wo Wu Biological: First Subject Enrolled in Phase II Clinical Trial of House Dust Mite Membrane Agent
People’s Financial News, April 8 — Our Biotech ( 300357 ) announced on April 8 that the company’s developed “Dust Mite Membrane Agent” has completed the enrollment of the first subject in the clinical study “Evaluation of the efficacy and safety of sublingual administration of ‘Dust Mite Membrane Agent’ in Chinese adults with dust mite allergic rhinitis — a randomized, double-blind, placebo-controlled Phase II clinical trial” at Tongji Hospital affiliated with Tongji Medical College, Huazhong University of Science and Technology, officially entering this clinical trial.